<< Previous article
Good Manufacturing P...
Next article > >
SAMPS Sales and...

New Tool to Assess Pyrogenic Risk in Pharmaceutical Processes

: 14 Jun 2019 - 31 Jul 2019

Sector: Other, Pharmaceutical

Type: Recorded


Webinar recorded: April 9, 2019

 

Preventing and assessing pyrogenic risk is key for product quality and patient safety. Subcellular components from microorganisms remaining from the production process can be a source of pyrogens as these substances are not eliminated by classical filtration or sterilization steps.

 

This pyrogenic risk cannot be solely attributed to endotoxins. The Monocyte Activation Test (MAT) is currently the only in vitro method designed for the detection of both endotoxins and non-endotoxin pyrogens (NEPs) that is supported by international regulations.

 

To learn more about this powerful tool to assess
pyrogenic risk in the pharmaceutical process:

WatchOurwebinarMagenta

 

To learn more about the validation method and results, Click Here

<< Previous article
Good Manufacturing P...
Next article > >
SAMPS Sales and...



Get our eNewsletter

Get the latest microbiology news every week - straight to your inbox!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS